Transplantation market is predicted to reach USD ~31.9 billion at a CAGR of ~9.50% during the forecast period 2023 to 2032.

Market Research Future (MRFR) has published a cooked research report on the “Global Transplantation Market” that contains information from 2018 to 2032. The Transplantation market is estimated to register a CAGR of 9.50% during the forecast period of 2023 to 2032.

Market Highlights

The global transplantation market is accounted to register a CAGR of 9.50% during the forecast period (2023-2032) and is estimated to reach USD 31.9 Billion by 2032.

The market for organ and tissue transplantation from donors to recipients is referred to as the "transplantation market." The rising need for organ transplants and tissue transplants brought on by the rising incidence of chronic diseases is what propels this market. It covers a range of transplantation procedures, including kidney, liver, heart, and lung transplants, and is successful only with the use of a combination of medical know-how, surgical skills, and immunosuppressive medications.

Segment Analysis

The global transplantation market has been segmented based product type, application and end user.

On the basis of product type, the market is segmented into tissue products, immunosuppressive drugs, and preservation solutions. Tissue products segment dominated the global market in 2022. The main products used during tissue or organ transplantation include tissue products, immunosuppressants, and preservation solutions.

Based on application, the global transplantation market has been segmented into organ transplantation and tissue transplantation. Tissue transplantation segment dominated the global market in 2022. This is because replacing the skin, cornea, bones, heart valves, tendons, nerves, and veins is one of the most common surgical procedures performed globally.

Based on end user, the global transplantation market has been segmented into hospitals, transplantation centers, and others. Hospitals segment dominated the global transplantation market in 2022. The majority of organ and tissue transplant surgeries take place in hospitals.

Explore In-depth Details: Transplantation Market Research Report

Regional Analysis

The global Transplantation market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Transplantation market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Transplantation market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Transplantation market comprises of Middle East, Africa, and Latin America.

The North America Transplantation Market dominated this market in 2022 (45.80%). High-quality healthcare facilities and the local presence of multiple significant biotechnology and medical device companies, such as Stryker, Arthrex, Inc., Zimmer Biomet, Medtronic, and Novartis AG, are supporting the market's rise. A widening gap has developed over the past ten years between the supply and demand for transplantable organs such kidneys, livers, and hearts.

Moreover, in 2022, Europe's transplant market had a sizable portion of the market. The market is expected to expand over the projected period as a result of the rising frequency of chronic illnesses. It's expected that important market players will launch more goods over the forecast period.

Additionally, from 2023 to 2032, the Asia Pacific Transplantation Market is anticipated to experience significant expansion. This is a result of both the growing healthcare infrastructure in Asian countries like India, Thailand, the Philippines, and Indonesia and the rising stem cell research to generate tissue and organs in vitro.

Furthermore, the rest of the world's Transplantation market is divided into the Middle East, Africa, and Latin America. The region's demand for organ and tissue transplantations is met by the Latin America Transplantation Market. The market offers a variety of transplantation choices, such as kidney, liver, heart, and lung transplants, to enhance patient outcomes and meet the healthcare needs of Latin American nations due to the rising prevalence of chronic diseases and developments in medical procedures.

MRFR recognizes the following companies as the key players in the global Transplantation market— Novartis AG, Teva Pharmaceutical Industries Ltd., Arthrex, Inc., Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation), BioLife Solutions, TransMedics, F., Hoffmann-La Roche Ltd, Zimmer Biomet, and Astellas Pharma Inc.

Key Findings of the Study

• The global transplantation market is expected to reach USD 31.9 Billion by 2032, at a CAGR of 9.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the expanding stem cell research to create tissue and organs in vitro as well as the expanding healthcare infrastructure in Asian nations including India, Thailand, the Philippines, and Indonesia.


• Based on end user, the hospitals segment was attributed to holding the largest market in 2022.


• Novartis AG, Teva Pharmaceutical Industries Ltd., Arthrex, Inc., Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation), BioLife Solutions, TransMedics, F., Hoffmann-La Roche Ltd, Zimmer Biomet, and Astellas Pharma Inc.